Since 2001, the Cancer Drug Development Forum (CDDF) has served as a trusted space for all stakeholders in cancer drug development to facilitate dialogue, debate and communication, fostering innovation to accelerate access to new treatments for patients.
The CDDF champions progress by hosting dynamic conferences, workshops, webinars, and projects that bring together stakeholders involved in oncology. In a neutral, non-competitive environment, we foster productive dialogue and open, respectful interactions in collaboration with the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and regulators from Europe and worldwide, alongside with academic researchers, pharmaceutical companies, HTA bodies, and patient advocates. Together, we accelerate breakthroughs and access to effective treatments for all patients.
As a key part of the effort, the CDDF holds its Annual Conference that gathers key stakeholders and experts to address challenges and opportunities in oncology drug development. This interactive three-day meeting features plenary lectures with moderated discussions, offering multistakeholder perspectives and unique networking opportunities.
In addition to the Conference, the CDDF organizes workshops, webinars and EU-level projects to facilitate multi-stakeholder collaboration on topical issues in the field of oncology. The responsive nature of the CDDF platform enables the oncology community to initiate timely conversations to reflect current and pressing needs. We continue pioneering progress through upcoming programs, which explore the impact of digital AI approaches in discovery research and global and EU regulatory landscapes.
Through the publication of white papers, the CDDF goes the extra mile by translating its meeting outcomes into actionable insights, driving incremental, significant shifts in oncology.
We believe that continued dialogue and active collaboration are key to improving cancer treatments and accelerating patient access. We welcome all our stakeholders to join us in advancing this mission and making their voices heard.